VTL — VGI Health Technology Share Price
Last trade - 00:00- AU$3.60m
- AU$3.83m
- AU$0.00m
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | n/a | ||
| Price to Tang. Book | n/a | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 51,428.13 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | n/a | ||
| Return on Equity | n/a | ||
| Operating Margin | -1403614.29% | ||
Financial Summary
| Year End 30th Jun | Unit | 2015 | 2016 | 2017 | 2018 | 2019 | 2020E | 2021E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | AU$m | 1.78 | 0.1 | 0.08 | n/a | 0 | n/a | n/a | -90.97% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
VGI Health Technology Limited is an Australia-based biotechnology company. The Company’s MELT3 formulation of Tocotrienols (T3s) is designed to be dissolved in the mouth and then swallowed, which is used for certain non-disease and self-limiting exercise related indications, such as reduction of delayed onset muscle soreness (DOMS), improved muscle recovery after exercise and improved maintenance of muscle power. MELT3 is designed for nutraceuticals and dietary supplements. Its TransT3, a transmucosal delivery platform for T3s, is designed to enhance absorption of the T3s by facilitating sublingual and buccal (transmucosal) absorption. T3s are absorbed into the capillaries below the sublingual and buccal mucosa and then released into the blood stream. Its Tocotrienol ProDrugs (TPD) is a prodrug delivery platform for T3s designed to enhance absorption of T3s into the lymphatic system of the gut and release of T3s into the blood stream.
Directors
- Last Annual
- June 30th, 2019
- Last Interim
- December 31st, 2019
- Incorporated
- September 22nd, 2004
- Public Since
- May 28th, 2021
- No. of Shareholders
- 3,805
- Sector
- Biotechnology & Medical Research
- Industry
- Healthcare
- Exchange
- National Stock Exchange of Australia
- Shares in Issue
- 179,998,454
- Address
- Level 45, 19 Martin Place, SYDNEY, 2000
- Web
- https://vgiht.com/
- Phone
- +61 82798908
- Auditors
- Hall Chadwick
Upcoming Events for VTL
Similar to VTL
IQX
National Stock Exchange of Australia
FAQ
As of Today at 19:03 UTC, shares in VGI Health Technology are trading at AU$0.02. This share price information is delayed by 15 minutes.
Shares in VGI Health Technology last closed at AU$0.02 and the price had moved by -33.33% over the past 365 days. In terms of relative price strength the VGI Health Technology share price has underperformed the ASX All Ordinaries Index by -36.23% over the past year.
There is no consensus recommendation for this security.
VGI Health Technology does not currently pay a dividend.
VGI Health Technology does not currently pay a dividend.
VGI Health Technology does not currently pay a dividend.
To buy shares in VGI Health Technology you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of AU$0.02, shares in VGI Health Technology had a market capitalisation of AU$3.60m.
Here are the trading details for VGI Health Technology:
- Country of listing: Australia
- Exchange: NSX
- Ticker Symbol: VTL
Based on an overall assessment of its quality, value and momentum VGI Health Technology is currently classified as a . The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
We could not find analyst target price data for this security.
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like VGI Health Technology. Over the past six months, its share price has underperformed the ASX All Ordinaries Index by -11%.
As of the last closing price of AU$0.02, shares in VGI Health Technology were trading -53.39% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The VGI Health Technology PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at AU$0.02.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
VGI Health Technology's management team is headed by:
- Louis Panaccio - NEC
- Gregory Starr - SEC
- Weidong Chen - NED
- Wei Jiang - NED
- Glenn Tong - NED
- Steven Yu - NED